logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (vii) All inpatient clients, age at first use distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates6.845.528.211.14.32.30.90.821.4115081075
Cocaine6.337.226.816.17.84.21.30.422.61080140
Stimulants17.255.916.95.72.50.90.50.419.03271210
Hypnotics and sedatives10.224.416.710.89.67.06.015.329.11009261
Hallucinogens22.261.113.90.02.80.00.00.017.7367
Volatile substances46.242.77.31.90.01.30.30.316.731410
Cannabis 38.043.910.64.41.80.70.30.217.53000301
Other substances 23.344.412.95.04.12.41.96.021.4417259
Total14.145.422.69.24.02.21.11.420.8206352263

Notes:

 Countries reporting data: BE, BG, CZ, DK, DE, IE, EL, FR, CY, LV, LU,HU, AT, RO, SK, FI, SE, HR, TR. 

 Last data available from Belgium refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table 109 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 14 July 2010